1. Home
  2. WEYS vs RZLT Comparison

WEYS vs RZLT Comparison

Compare WEYS & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Weyco Group Inc.

WEYS

Weyco Group Inc.

HOLD

Current Price

$34.54

Market Cap

331.9M

ML Signal

HOLD

Logo Rezolute Inc. (NV)

RZLT

Rezolute Inc. (NV)

HOLD

Current Price

$3.33

Market Cap

321.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WEYS
RZLT
Founded
1906
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
331.9M
321.6M
IPO Year
1995
2011

Fundamental Metrics

Financial Performance
Metric
WEYS
RZLT
Price
$34.54
$3.33
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$9.67
AVG Volume (30 Days)
12.0K
1.3M
Earning Date
05-05-2026
05-13-2026
Dividend Yield
3.24%
N/A
EPS Growth
N/A
26.32
EPS
0.64
N/A
Revenue
$276,169,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$54.14
N/A
Revenue Growth
N/A
N/A
52 Week Low
$27.25
$1.07
52 Week High
$35.69
$11.46

Technical Indicators

Market Signals
Indicator
WEYS
RZLT
Relative Strength Index (RSI) 55.13 53.29
Support Level $30.62 $2.93
Resistance Level N/A $3.60
Average True Range (ATR) 1.38 0.21
MACD 0.10 -0.00
Stochastic Oscillator 75.59 68.55

Price Performance

Historical Comparison
WEYS
RZLT

About WEYS Weyco Group Inc.

Weyco Group Inc is a company, engaged in the manufacturing, designing, and distribution of footwear. The company designs and markets footwear for men, women, and children. It markets its apparel, accessories, and footwear under the brand names of Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company organizes its business into two segments; the North American wholesale operations and the North American retail operations. The majority of the company's revenue is generated from the wholesale segment under which its products are sold to footwear, department, and specialty stores, as well as e-commerce retailers. The company has operational footprints in the United States which generates key revenue, Canada, South Africa, and Australia.

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.

Share on Social Networks: